Ownership history in RENAISSANCE TECHNOLOGIES LLC · 18 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in PHARMACYTE BIOTECH INC (PMCB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 94,036 | +14,036 | +17.5% | 0.00% | $68K | $0.72 |
| 2025 Q3 | ADDED | 80,000 | +30,200 | +60.6% | 0.00% | $78K | $0.97 |
| 2025 Q2 | ADDED | 49,800 | +300 | +0.6% | 0.00% | $54K | $1.09 |
| 2025 Q1 | ADDED | 49,500 | +200 | +0.4% | 0.00% | $62K | $1.25 |
| 2024 Q4 | REDUCED | 49,300 | -400 | -0.8% | 0.00% | $77K | $1.57 |
| 2024 Q3 | ADDED | 49,700 | +1,200 | +2.5% | 0.00% | $95K | $1.91 |
| 2024 Q2 | ADDED | 48,500 | +4,700 | +10.7% | 0.00% | $95K | $1.96 |
| 2024 Q1 | ADDED | 43,800 | +5,700 | +15.0% | 0.00% | $104K | $2.37 |
| 2023 Q4 | ADDED | 38,100 | +5,200 | +15.8% | 0.00% | $82K | $2.16 |
| 2023 Q3 | ADDED | 32,900 | +7,026 | +27.2% | 0.00% | $69K | $2.10 |
As of 2025 Q4 — sorted by position size